RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,874 | +22.0% | 26,958 | 0.0% | 0.04% | +26.7% |
| Q2 2023 | $66,317 | +8.8% | 26,958 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $60,926 | -35.2% | 26,958 | 0.0% | 0.03% | -41.2% |
| Q4 2022 | $94,083 | -90.6% | 26,958 | 0.0% | 0.05% | -91.0% |
| Q3 2022 | $998,000 | +94.9% | 26,958 | 0.0% | 0.56% | +102.9% |
| Q2 2022 | $512,000 | -29.7% | 26,958 | 0.0% | 0.28% | -12.0% |
| Q1 2022 | $728,000 | +19.9% | 26,958 | 0.0% | 0.32% | +26.9% |
| Q4 2021 | $607,000 | -14.1% | 26,958 | 0.0% | 0.25% | -23.4% |
| Q3 2021 | $707,000 | -18.1% | 26,958 | 0.0% | 0.32% | -19.2% |
| Q2 2021 | $863,000 | -9.1% | 26,958 | 0.0% | 0.40% | -16.6% |
| Q1 2021 | $949,000 | +9.7% | 26,958 | 0.0% | 0.48% | +1.7% |
| Q4 2020 | $865,000 | -14.7% | 26,958 | 0.0% | 0.47% | -25.4% |
| Q3 2020 | $1,014,000 | -15.9% | 26,958 | 0.0% | 0.64% | -22.9% |
| Q2 2020 | $1,206,000 | – | 26,958 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |